DataArt, a global software engineering firm, is thrilled to announce its upcoming online panel discussion titled "DiGA for Pharma as Business Growth Opportunity." The event will unite professionals from the pharmaceutical, technology, and regulatory sectors to explore the transformative power of digital health apps. This discussion aims to delve into key topics, including:
- Understanding why the pharmaceutical industry should be highly interested in DiGA
- Exploring the inherent suitability of DiGAs for the pharmaceutical sector
- What is essential for Pharma companies to successfully manage their first DiGA project
- Addressing regulatory challenges and considerations in adopting DiGAs
- Identifying the ideal DiGA case for the pharmaceutical sector
This event will feature an exceptional lineup of speakers. Joining us will be Dr. Marcus Rudolf Goetz, Head of Research and Development at Dr. Pfleger Arzneimittel; Olga Romanova, Engagement Manager at DataArt; Oliver Hilgers, Head of Digital Health at NEXTEC Medical; and Dr. Patrik Scholler, a Business Strategy Consultant specializing in Life Sciences.
Through this panel discussion, attendees will gain valuable insights into the advantages that DiGAs offer to the pharmaceutical industry. The session will highlight how DiGAs are uniquely well-suited for the pharma sector, including their potential to enhance patient engagement, improve medication adherence, and enable personalized healthcare experiences. Additionally, the discussion will identify the ideal DiGA case for the pharmaceutical sector, providing attendees with a clear understanding of the potential applications and benefits.
To register and further information, please follow the link:
About DataArtDataArt is a global software engineering firm that takes a uniquely human approach to solving problems. With over 25 years of experience, teams of highly trained engineers around the world, deep industry sector knowledge and ongoing technology research, the company helps clients create custom software that improves their operations and opens new markets.